Home » AstraZeneca to Manufacture Oxford University’s COVID-19 Vaccine
AstraZeneca to Manufacture Oxford University’s COVID-19 Vaccine
AstraZeneca has entered into an agreement with Oxford University to develop and distribute Oxford’s COVID-19 vaccine.
If clinical trials show that the vaccine is effective, AstraZeneca will lead the development, worldwide manufacturing and distribution of the vaccine.
The vaccine candidate entered phase 1 trials last week in healthy volunteers aged 18 to 55 across five centers in southern England.
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May